{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:36Z","timestamp":1707524916004},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.7759\/cureus.35660","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T23:45:06Z","timestamp":1677714306000},"source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia"],"prefix":"10.7759","author":[{"given":"Sangeetha","family":"Isaac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Afraz","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalom","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Kyei-Nimako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy086","article-title":"Pulmonary cryptococcosis: a review of pathobiology and clinical aspects","volume":"57","author":"Setianingrum F","year":"2019","unstructured":"Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019, 57:133-50. 10.1093\/mmy\/myy086","journal-title":"Med Mycol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.4.943","article-title":"Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids","volume":"100","author":"Meduri GU","year":"1991","unstructured":"Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991, 100:943-52. 10.1378\/chest.100.4.943","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00472-7","article-title":"Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran","volume":"185","author":"Salehi M","year":"2020","unstructured":"Salehi M, Ahmadikia K, Badali H, Khodavaisy S. Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran. Mycopathologia. 2020, 185:607-11. 10.1007\/s11046-020-00472-7","journal-title":"Mycopathologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcaa255","article-title":"Post-COVID-19 pneumonia pulmonary fibrosis","volume":"113","author":"Tale S","year":"2020","unstructured":"Tale S, Ghosh S, Meitei SP, Kolli M, Garbhapu AK, Pudi S. Post-COVID-19 pneumonia pulmonary fibrosis. QJM. 2020, 113:837-8. 10.1093\/qjmed\/hcaa255","journal-title":"QJM"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.457","article-title":"Pulmonary cryptococcosis complicating post-COVID-19 pulmonary fibrosis","volume":"160","author":"Isaac S","year":"2021","unstructured":"Isaac S, Pasha MA, Isaac S, Lal A, Kyei-Nimako E. Pulmonary cryptococcosis complicating post-COVID-19 pulmonary fibrosis. Chest. 2021, 160:A467. 10.1016\/j.chest.2021.07.457","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13746","article-title":"Assessment and characterisation of post-COVID-19 manifestations","volume":"75","author":"Kamal M","year":"2021","unstructured":"Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021, 75:e13746. 10.1111\/ijcp.13746","journal-title":"Int J Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5578\/tt.70353","article-title":"Post-COVID-19 pulmonary sequelae: longterm follow-up and management [Article in Turkish]","volume":"68","author":"T\u00fcrkta\u015f H","year":"2020","unstructured":"T\u00fcrkta\u015f H, O\u011fuz\u00fclgen \u0130K. Post-COVID-19 pulmonary sequelae: longterm follow-up and management [Article in Turkish]. Tuberk Toraks. 2020, 68:419-29. 10.5578\/tt.70353","journal-title":"Tuberk Toraks"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0022-2019","article-title":"Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis","volume":"28","author":"Collins BF","year":"2019","unstructured":"Collins BF, Raghu G. Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis. Eur Respir Rev. 2019, 28:190022. 10.1183\/16000617.0022-2019","journal-title":"Eur Respir Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini BM","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, et al.. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020, 324:1307-16. 10.1001\/jama.2020.17021","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID steroid 2 randomized trial","volume":"326","author":"Munch MW","year":"2021","unstructured":"Munch MW, Myatra SN, Vijayaraghavan BK, et al.. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID steroid 2 randomized trial. JAMA. 2021, 326:1807-17. 10.1001\/jama.2021.18295","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06573-1","article-title":"Dexamethasone 12\u00a0mg versus 6\u00a0mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial","volume":"48","author":"Granholm A","year":"2022","unstructured":"Granholm A, Munch MW, Myatra SN, et al.. Dexamethasone 12\u00a0mg versus 6\u00a0mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med. 2022, 48:45-55. 10.1007\/s00134-021-06573-1","journal-title":"Intensive Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3001","article-title":"Long term respiratory complications of covid-19","volume":"370","author":"Fraser E","year":"2020","unstructured":"Fraser E. Long term respiratory complications of covid-19. BMJ. 2020, 370:m3001. 10.1136\/bmj.m3001","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24084","article-title":"COVID-19-associated pulmonary cryptococcosis: a rare case presentation","volume":"26","author":"Sharma S","year":"2022","unstructured":"Sharma S, Agrawal G, Das S. COVID-19-associated pulmonary cryptococcosis: a rare case presentation. Indian J Crit Care Med. 2022, 26:129-32. 10.5005\/jp-journals-10071-24084","journal-title":"Indian J Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030143","article-title":"Pulmonary cryptococcosis after recovery from COVID-19 in an immunocompetent patient: a rare case report","volume":"101","author":"Choi HS","year":"2022","unstructured":"Choi HS. Pulmonary cryptococcosis after recovery from COVID-19 in an immunocompetent patient: a rare case report. Medicine (Baltimore). 2022, 101:e30143. 10.1097\/MD.0000000000030143","journal-title":"Medicine (Baltimore)"},{"key":"ref16","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. (2021). https.\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/cryp...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect JR","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, et al.. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010, 50:291-322. 10.1086\/649858","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/111656-pulmonary-cryptococcosis-and-pulmonary-fibrosis-a-complication-of-covid-19-pneumonia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:48Z","timestamp":1707508788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/111656-pulmonary-cryptococcosis-and-pulmonary-fibrosis-a-complication-of-covid-19-pneumonia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.35660","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}